000 02155nam  2200325za 4500
0019.815247
003CaOODSP
00520221107141953
007cr |||||||||||
008160414s2016    onc     ob   f000 0 eng d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH113-9/2016-14E-PDF
24500|aAmitraz |h[electronic resource].
260 |aOttawa : |bHealth Canada, |c2016.
300 |a7 p.
4901 |aProposed registration decision, |x1925-0886 ; |vPRD2016-14
500 |aIssued also in French under title: Amitraze.
500 |a"31 March 2016."
504 |aIncludes bibliographical references.
520 |aThe original evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. Although the risks and value have been found to be acceptable when all risk reduction measures are followed, as a condition of the original registrations, additional scientific information was requested from the applicant in order to confirm the scientific assumptions that formed part of the risk assessment for the Apivar Strips product. In support of the request to renew the conditional registrations, a rationale for renewal of the registrations was provided. The requirement to submit additional scientific information as a condition of registration remains. This Overview describes the key points of the original evaluation, while the Science Evaluation in ERC2013-04, Amitraz provides detailed technical information on the human health, environmental and value assessments of Amitraz Technical and Apivar Strips.
530 |aIssued also in printed form.
69207|2gccst|aPesticides
69207|2gccst|aInsecticides
69207|2gccst|aSafety standards
69207|2gccst|aCertification
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tAmitraze |w(CaOODSP)9.815250
830#0|aProposed registration decision,|x1925-0886 ; |vPRD2016-14|w(CaOODSP)9.504464
85640|qPDF|s73 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H113-9-2016-14-eng.pdf